Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Predictive Oncology Inc

POAI
Current price
0.88 USD 0 USD (0.00%)
Last closed 0.92 USD
ISIN US74039M2008
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 6 000 498 USD
Yield for 12 month -72.06 %
1Y
3Y
5Y
10Y
15Y
POAI
21.11.2021 - 28.11.2021

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania. Address: 91 43rd Street, Pittsburgh, PA, United States, 15201

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3 USD

P/E ratio

Dividend Yield

Current Year

+1 780 093 USD

Last Year

+1 505 459 USD

Current Quarter

+278 722 USD

Last Quarter

+419 646 USD

Current Year

+433 407 USD

Last Year

+1 000 352 USD

Current Quarter

-38 411 USD

Last Quarter

+69 666 USD

Key Figures POAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 437 984 USD
Operating Margin TTM -1144.24 %
PE Ratio
Return On Assets TTM -55.8 %
PEG Ratio
Return On Equity TTM -149.36 %
Wall Street Target Price 3 USD
Revenue TTM 1 748 456 USD
Book Value 0.72 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -43.1 %
Dividend Yield
Gross Profit TTM 1 000 352 USD
Earnings per share -3.34 USD
Diluted Eps TTM -3.34 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics POAI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History POAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 24.04.2023
Dividend Date 29.10.2019

Stock Valuation POAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.9269
Price Sales TTM 3.4319
Enterprise Value EBITDA -0.5121
Price Book MRQ 1.466

Financials POAI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators POAI

For 52 weeks

0.85 USD 4.1 USD
50 Day MA 1.02 USD
Shares Short Prior Month 81 078
200 Day MA 2.03 USD
Short Ratio 0.42
Shares Short 78 150
Short Percent 1.19 %